Tag: ASCO 2022index/list_13474_1

Women With HER2+ Metastatic Breast Cancer Are Living Longer

Select Patients With Breast Cancer May Skip RT After Lumpectomy

Treating Bone Loss Ups Survival for Patients With Breast Cancer

Pseudocirrhosis in Breast Cancer May Signal Liver Metastases

How FDA Is Working to Improve Oncology Drug Development

Teclistamab Shows ‘Promising’ Activity in R/R Multiple Myeloma

Enhertu Benefit in HER2-Low Breast Cancer: ‘Practice Changing’

Targeted Therapy an ‘Important Advance’ in Childhood Glioma

Sacituzumab a ‘Step Forward’ in Breast Cancer Unmet Need

Panitumumab Beats Bevacizumab in Left-Sided mCRC